Patheon has bought hard-to-make API specialist Irix Pharmaceuticals

By Gareth Macdonald

- Last updated on GMT

Irix facility in Greenville, South Carolina, US
Irix facility in Greenville, South Carolina, US

Related tags Pharmacology Pharmaceutical drug

Patheon has bought hard-to-manufacture active pharmaceutical ingredient (API) specialist, Irix Pharmaceuticals.

The deal – financial details of which have not been disclosed – will add Irix's small-scale manufacturing facility in Florence, South Carolina and large scale production site in neighbouring Greenville to Patheon’s offering.

The agreement is expected to complete in 60 days, pending approval by industry regulators.

Irix’s focus is the production of difficult to make active pharmaceutical ingredients, including high potency ingredients and controlled substances.

Patheon is a business unit of DPx Holdings BV, which is the contract manufacturing organisation (CMO) that formed in 2014 through the merger of the previous entity Patheon and Royal DSM's pharmaceutical products business.

Lukas Utiger, president, DPx Fine Chemicals  said the deal allows Patheon to "secure important capabilities​" adding that the Irix operations complement the firm's existing capabilities in Europe.

The acqusition is in keeping with DPx comments about the market last year, when it said the CMO industry with ripe for consolidation​ citing customer demand for single suppliers as the driver.

At the time, president of pharma development services Mike Lehmann told us the firm was looking to grow through acqusition in a couple of key areas.

Related news

Show more

Related products

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Access GMP process liquids

Access GMP process liquids

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Apr-2023 | Product Brochure

Accelerate your development and manufacturing of life-changing medicines with a reliable supply of your critical GMP-manufactured process liquids. Gibco...

A Guide Through the API Drug Development Pipeline.

A Guide Through the API Drug Development Pipeline.

Content provided by Lonza Small Molecules | 04-Apr-2023 | Insight Guide

With the complexities associated with API and HPAPI drug development, it’s necessary to lean on the experts. With Q&A sections, insights and articles...

Related suppliers

Follow us

Products

View more

Webinars